The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Celularity (Inst); Janssen Diagnostics (Inst); MedImmune (Inst)
Updated phase 1 results of teclistamab, a B-cell maturation antigen (BCMA) × CD3 bispecific antibody, in relapsed/refractory multiple myeloma (MM).
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - BMS
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Pfizer; Regeneron
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
 
Alfred L. Garfall
Consulting or Advisory Role - GlaxoSmithKline; Janssen Oncology
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pfizer; Regeneron; Roche/Genentech; Takeda
 
Niels W.C.J. van de Donk
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Cellectis; Janssen; Novartis
 
Hareth Nahi
No Relationships to Disclose
 
Jesús F. San-Miguel
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst); Takeda (Inst)
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi
Speakers' Bureau - Amgen; Celgene
 
Laura Rosiñol
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Sanofi
 
Ajai Chari
Consulting or Advisory Role - Abbvie; Amgen; Antengene; Bristol-Myers Squibb/Celgene; Genentech; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; OncoPeptides; Seagen; Secura Bio; Shattuck Labs; Takeda
Research Funding - Amgen; Celgene; Janssen; Pharmacyclics; Seagen; Takeda
 
Manisha Bhutani
No Relationships to Disclose
 
Lionel Karlin
Employment - Aguettant (I)
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Travel, Accommodations, Expenses - Amgen; Janssen-Cilag; Takeda
 
Lotfi Benboubker
No Relationships to Disclose
 
Lixia Pei
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Raluca Verona
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Suzette Girgis
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson
 
Tara Stephenson
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Jenna D. Goldberg
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Arnob Banerjee
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics